Clinical Course and Outcomes of COVID-19 Infection in Patients Treated with Rituximab: A Tertiary Care Center Experience

INTRODUCTION: Patients receiving rituximab (RTX) may be at increased risk for severe Coronavirus infections and worse outcomes compared with the general population. Because of the conflicting results concerning the effect of RTX on the clinical course and outcomes of COVID-19 infection, we aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Alhowaish, Thamer S, Alhamadh, Moustafa S, Mathkour, Alaa, Alamoudi, Marwan, Alqahtani, Hossam Ali, Alrashid, Abdulrahman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473421/
https://www.ncbi.nlm.nih.gov/pubmed/37663367
http://dx.doi.org/10.2147/OARRR.S424316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473421/
https://www.ncbi.nlm.nih.gov/pubmed/37663367
http://dx.doi.org/10.2147/OARRR.S424316

Ejemplares similares